SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in patients with hemoglobin SC, a milder form of sickle cell disease (SCD), a ...

Ahmar U. Zaidi, MD: As far as preventive therapies go, hydroxyurea is the mainstay of therapy in sickle cell disease. And hydroxyurea is quite an interesting drug that has been studied very ...

Hydroxyurea remains effective over the long term among children with sickle cell disease, real-world data suggested. The average time on hydroxyurea was 5 years, with many children on the therapy for ...

Hydroxyurea may falsely elevate sensor glucose results from certain CGM systems. The prescribing information for hydroxyurea has been updated to include information regarding patients who use ...

Adding hydroxyurea to the selective inhibitor of Janus kinase 1 and 2 could elicit a high clinical response and increased ruxolitinib exposure for patients with hyperproliferative forms of ...

Please provide your email address to receive an email when new articles are posted on . Use of hydroxyurea did not reduce ovarian reserve among girls and young women with sickle cell disease.

Researchers have revealed that hydroxyurea significantly reduces infections in children with sickle cell anemia. Their findings enhance strong evidence of hydroxyurea's effectiveness and could ...

Heart abnormalities are common complications of sickle cell anemia (SCA) that can contribute to severe disease symptoms and even death. A study published today in the journal Blood Advances is the ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Children from sub-Saharan Africa with sickle cell anemia treated with hydroxyurea for 6 months ...